# Stroke Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stroke-care

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.strokemedical.com
- Total disclosed funding: $14M
- Latest round: Series C (Jul 16, 2020)
- Investors on record: 6

## About

Based in Shanghai, China and established in 2016, Stroke Care is a medical technology that engages in the research and development of interventional medical equipment for stroke treatment. The company had obtained NMPA approvals for four ischemic stroke treatment devices.

The company mainly provides ischemic stroke treatment products, including acute ischemic stroke, intracranial stenosis and hemorrhagic stroke treatment products, such as thrombectomy device, microcatheter, left atrial appendage occluder, etc.

The company expects to commercialize 9 currently late-stage product candidates in 2021, and 10 currently earlier-stage product candidates between 2022 and 2025, including sirolimus intracranial drug-eluting balloon catheter for intracranial stenosis treatment.

## Funding rounds

- Series C, Jul 16, 2020 — LYFE Capital, Sherpa Healthcare Partners
- Series B, Sep 9, 2019, $14M — Grand Yangtze Capital, Hidea Investment, Sharewin Investment
- Series A, Jul 17, 2018 — Fosun International

## Investors

- Fosun International (https://capitalatlas.ai/funds/fosun-international) — Series A
- Grand Yangtze Capital (https://capitalatlas.ai/funds/grand-yangtze-capital) — Series B
- Hidea Investment (https://capitalatlas.ai/funds/hidea-investment) — Series B
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series B
- LYFE Capital — Series C
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series C